| Literature DB >> 26883169 |
Alexandra Arranja1,2, Oleksandra Ivashchenko2,3,4, Antonia G Denkova2, Karolina Morawska5, Sandra van Vlierberghe5, Peter Dubruel5, Gilles Waton1, Freek J Beekman2,3,4, François Schosseler1, Eduardo Mendes6.
Abstract
Optimal biodistribution and prolonged circulation of nanocarriers improve diagnostic and therapeutic effects of enhanced permeability and retention-based nanomedicines. Despite extensive use of Pluronics in polymer-based pharmaceuticals, the influence of different poly(ethylene oxide) (PEO) block length and aggregation state on the biodistribution of the carriers is rather unexplored. In this work, we studied these effects by evaluating the biodistribution of Pluronic unimers and cross-linked micelles with different PEO block size. In vivo biodistribution of (111)In-radiolabeled Pluronic nanocarriers was investigated in healthy mice using single photon emission computed tomography. All carriers show fast uptake in the organs from the reticuloendothelial system followed by a steady elimination through the hepatobiliary tract and renal filtration. The PEO block length affects the initial renal clearance of the compounds and the overall liver uptake. The aggregation state influences the long-term accumulation of the nanocarriers in the liver. We showed that the circulation time and elimination pathways can be tuned by varying the physicochemical properties of Pluronic copolymers. Our results can be beneficial for the design of future Pluronic-based nanomedicines.Entities:
Keywords: Pluronic; SPECT; micelles; unimers
Mesh:
Substances:
Year: 2016 PMID: 26883169 DOI: 10.1021/acs.molpharmaceut.5b00958
Source DB: PubMed Journal: Mol Pharm ISSN: 1543-8384 Impact factor: 4.939